Yanikoglu, R.; Karakas, C.Y.; Ciftci, F.; Insel, M.A.; Karavelioglu, Z.; Varol, R.; Yilmaz, A.; Cakir, R.; Uvet, H.; Ustundag, C.B.
Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate. Pharmaceutics 2024, 16, 837.
https://doi.org/10.3390/pharmaceutics16060837
AMA Style
Yanikoglu R, Karakas CY, Ciftci F, Insel MA, Karavelioglu Z, Varol R, Yilmaz A, Cakir R, Uvet H, Ustundag CB.
Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate. Pharmaceutics. 2024; 16(6):837.
https://doi.org/10.3390/pharmaceutics16060837
Chicago/Turabian Style
Yanikoglu, Reyhan, Canan Yagmur Karakas, Fatih Ciftci, Mert Akın Insel, Zeynep Karavelioglu, Rahmetullah Varol, Abdurrahim Yilmaz, Rabia Cakir, Hüseyin Uvet, and Cem Bulent Ustundag.
2024. "Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate" Pharmaceutics 16, no. 6: 837.
https://doi.org/10.3390/pharmaceutics16060837
APA Style
Yanikoglu, R., Karakas, C. Y., Ciftci, F., Insel, M. A., Karavelioglu, Z., Varol, R., Yilmaz, A., Cakir, R., Uvet, H., & Ustundag, C. B.
(2024). Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate. Pharmaceutics, 16(6), 837.
https://doi.org/10.3390/pharmaceutics16060837